Greeting from Director

To meet the challenge for the upcoming globalization era and AFTA – the pharmaceutical sector, without exception is required to perform improvements in all aspects. ASEAN HARMONIZATION in the health sector which is scheduled to be implemented in 2008 includes cGMP as a requirement which all pharmaceutical companies must meet.

With a strong commitment to manufacture quality and affordable products, OTTO has performed improvements in all sectors maximizing all her available resources. The company relies on Professional workforce such that any improvement process occurs swiftly without neglecting the benefits of all concerned.

The main focus of OTTO presently is the construction of a new plant which meets the cGMP and PICS standards and to develop human resources which are reliable and supportive towards achieving the company’s values!

Welcome to OTTO!

Jimmy Sudharta
CEO of Mensa Group

Company in Brief

PT OTTO Pharmaceutical Industries is part of Mensa Group; it is a pharmaceutical manufacturing company producing a variety of quality medicines with the aim to serve the people nationwide.

OTTO was established on the 8th April 1963 in Bandung, West Java. In 1981, the ownership of the company was taken over by Mensa Group, during which time a management re-organization took place including the improvement in the company’s accounting system and the addition of production facility within the plant. Since then OTTO continues to expand, developing both the manufacturing plant and the company’s human resources. In line with the confidence gained by the medical doctors and public towards the quality of OTTO’s products, provided OTTO the opportunity to improve her sales and market share.

In 1991, OTTO became one of the few pioneering pharmaceutical companies in the country which obtained the CPOB certificate. In June 2005, the company obtained ISO 9001:2000 certifications from RWTUV GmbH Germany (ISO international) as a reflection of its achievement in total quality management.

In the beginning of 2007, to meet the cGMP standard (required by BPOM - local ministry of Food and Medicines and in line to the Healthcare ASEAN Harmonization) and to manufacture products meeting International standard, Otto started planning on building a new manufacturing plant. For the whole new plant construction Otto appointed the world class consultant – NNE Pharmaplan – to meet the standard of cGMP, PIC’s and EU for its design concept.

And today, OTTO factory operates under two separates lines to run non-betalactam and cepalosphorin production. Its occupied by more than 20.000 sqm production building area, 3.000 sqm supporting facilities, 2.400 sqm central warehouse and over than 600 highly dedicated employees of manufacturing and quality management.

 

VISION

TO BECOME
GLOBALLY RESPECTED
AS A LEADING
PHARMACEUTICAL COMPANY

MISSION

TO SUPPORT QUALITY OF
HEALTH IMPROVEMENT
BY PRODUCING AND MARKETING
QUALITY INNOVATIVE PRODUCT
WITH ECONOMICAL VALUE FOR ALL

VALUES

MEETING COMMITMENT
ENSURING BALANCE & LASTING RELATIONSHIP
NURTURING INNOVATION
STRIVING FOR EXCELLENCE
ASSURING CONTINUOUS IMPROVEMENT

As a member of Mensa Group, we establish CSR footprint and understands the impact for environment and society from every angle and in every step in the value chain.

Mensa Care, consists of 4 cores :
SCIENCE & EDUCATION, HEALTHCARE, ENVIRONMENT and MOST HELPLESS.